Los Angeles Capital Management
VIR icon

Los Angeles Capital Management’s Vir Biotechnology VIR Stock Holding History

Los Angeles Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7K Sell
1,640
-18,840
-92% -$179K ﹤0.01% 1839
2026
Q1 		$184K Sell
20,480
-2,100
-9% -$16.7K ﹤0.01% 1168
2025
Q4 		$134K Sell
22,580
-18,630
-45% -$111K ﹤0.01% 1348
2025
Q3 		$235K Buy
41,210
+28,640
+228% +$146K ﹤0.01% 1218
2025
Q2 		$63.4K Buy
+12,570
New +$67.4K ﹤0.01% 1287
2025
Q1 		– Sell
-13,560
Closed -$99.5K – 1236
2024
Q4 		$99.5K Sell
13,560
-20
-0.1% -$158 ﹤0.01% 1086
2024
Q3 		$102K Buy
13,580
+249
+2% +$2.16K ﹤0.01% 1142
2024
Q2 		$119K Buy
+13,331
New +$128K ﹤0.01% 1151
2023
Q2 		– Sell
-23,257
Closed -$541K – 1300
2023
Q1 		$541K Sell
23,257
-39,668
-63% -$1.01M ﹤0.01% 835
2022
Q4 		$1.59M Sell
62,925
-949
-1% -$23.3K 0.01% 577
2022
Q3 		$1.23M Buy
63,874
+48,414
+313% +$1.23M 0.01% 628
2022
Q2 		$394K Sell
15,460
-24,689
-61% -$576K ﹤0.01% 1056
2022
Q1 		$1.03M Buy
40,149
+22,397
+126% +$664K ﹤0.01% 744
2021
Q4 		$743K Buy
17,752
+6,581
+59% +$258K ﹤0.01% 834
2021
Q3 		$486K Buy
11,171
+10
+0.1% +$433 ﹤0.01% 1052
2021
Q2 		$528K Sell
11,161
-600
-5% -$27.3K ﹤0.01% 1144
2021
Q1 		$603K Sell
11,761
-13,353
-53% -$720K ﹤0.01% 1128
2020
Q4 		$673K Buy
25,114
+12,036
+92% +$391K ﹤0.01% 1090
2020
Q3 		$449K Buy
+13,078
New +$563K ﹤0.01% 1124

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Los Angeles Capital Management's VIR Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Vir Biotechnology (VIR) stake by 92% in Q2 2026, selling an estimated $179K and leaving 1,640 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Los Angeles Capital Management first reported a position in VIR in Q3 2020 and has held it in 19 quarters since. The position peaked at $1.59M in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Los Angeles Capital Management held 1,640 shares of Vir Biotechnology worth $16.7K as of Q2 2026.
  • Los Angeles Capital Management sold 18,840 Vir Biotechnology shares in Q2 2026, an estimated $179K.
  • Vir Biotechnology made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1839 holding.
  • Los Angeles Capital Management first reported a position in Vir Biotechnology in Q3 2020 and has held it in 19 quarters since.
  • Los Angeles Capital Management's Vir Biotechnology position peaked at $1.59M in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.